Related content

Conversion from tacrolimus to neoral in liver and kidney transplant recipients

By Ott R.   Bussenius-Kammerer M.   Scholz D.   Neuhaus R.   Tolba R.H.   Fricke L.   Muller V.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3166-3168

Elsevier

Access to resources Recommend Favorite

Conversion From Neoral (Cyclosporine) to Tacrolimus of Kidney Transplant Recipients for Gingival Hyperplasia or Hypertrichosis

By Busque S.   Demers P.   St-Louis G.   Boily J.-G.   Tousignant J.   Lemieux F.   Smeesters C.   Corman J.   Daloze P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1247-1248

Elsevier

Access to resources Recommend Favorite

Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression

By Martins L.   Henriques A.C.   Dias L.   Sarmento A.M.   Pereira M.C.   Guimaraes S.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2636-2638

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus for refractory acute rejection in pediatric kidney transplant recipients: a single-center experience

By Ferraresso M.   Ghio L.   Edefonti A.   Garavaglia R.   Pozzoli E.   Berardinelli L.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3590-3591

Elsevier

Access to resources Recommend Favorite

Improvement of Nephrotoxicity, Hypertension, and Lipid Metabolism After Conversion of Kidney Transplant Recipients From Cyclosporine to Tacrolimus

By Friemann S.   Feuring E.   Padberg W.   Ernst W.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1240-1242

Elsevier

Access to resources Recommend Favorite